chrisvoncsefalvay/vaers-outcomes huggingface dataset:
temperature was like between 102.6 and 103.5; back hurts; couldn't even really move; woke up at the middle of the night; This is a spontaneous report from a contactable consumer. A 40-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the arm on 07Jan2021 13:00 at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included clonazepam. The patient had historical vaccine first dose of BNT162B2 for COVID-19 immunization and experienced tiredness. On unspecified date, the consumer stated, "I just want to, I didn't have, I was just little tired with the first shot I received. But I am little concerning on the second one like I woke up at the middle of the night, I got it yesterday at about 13:00. I woke up at about 2:00 in the morning on 08Jan2021 nd I couldn't even really move but then I was up for most of the night. My temperature is like  between 102.6 and 103.5 and my back hurts really bad. So, I am hoping that these are normal things but I am curious at any point is there something I should watch out for taking on that stuff further. The first shot was not anywhere near to bad which I know is to be expected but the second one being the worse, it's like dramatic, I have had a fever for I don't know like eighteen hours. Is there anything I should just make sure, or like this can be a normal side effect, correct?" The outcome of the events was unknown.
vial was initially stored in the fridge on 08-Jul-2022, and vaccines was administered on 10-Aug-2022; No adverse event; dose administered after 30-day use by date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day use by date), PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 08-Jul-2022, and vaccines was administered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 9-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 10-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 08-Jul-2022, and vaccines was administered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day use by date), PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 08-Jul-2022, and vaccines was administered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 08-Jul-2022, and vaccines was administered on 10-Aug-2022).    No concomitant medication was provided. No temperature excursions were reported. No treatment information was provided.
Patient brought elderly neighbor (90 yrs) in at the end of a COVID vaccine clinic to utilize leftover additional doses (from booster dose clinic)--after they were called in from a waiting list. Patient was accidentally offered a dose as well, as there were available doses upon their arrival, with clinic volunteers not recognizing that at 16 years she was too young for the vaccine.  Patients mom alerted the Dept of Health for around April 7th or 8th, as they needed to find a site for this patient to receive her booster dose. As she was under the approved age, the county could not immunize her and notified me as the oversight person for our now concluded vaccine clinics.  Patient was connected with an ongoing vaccine clinic with our hospital partner, and received her 2nd/booster dose of Moderna today at 10:00 am.  District requested that we submit a VAERS report on this error.
Got second dose on Wednesday afternoon. Felt extreme fatigue about 24 hours after, Thursday afternoon. Took a 2 hour nap. Also body aches/muscle soreness that seemed to exceed what I?d expect from normal workouts.  Friday morning felt fine until afternoon when severe fatigue set in - almost exactly 48 hours after I got the shot. Took a 1 hour nap and felt ok afterward.  But Friday night into Saturday did not sleep well. Had severe headache in middle of the night, and woke up feeling like I had a head cold, and feeling some chills. Headache resolved with Tylenol.
Who: What: Vasovagel Where: Observation When: 5/5/2021 @ 1700 How: Response to second vaccine Pt was taken by EMS and was only able to get mothers information which is listed above. Pt is 18, email and phone number are posted. 911 called by medic, taken to ER on request of mother. Pt stable at time of transfer.
24 hours after the vaccine (Wed around 1), I was feeling weak and could barely keep my eyes open. I ran a fever as high as 102 and stayed around 100 for at least the next 18 few hours. All I wanted to do was sleep and my head hurt . It felt like I had COVID all over again. (I was tested for COVID 1/16/21 and confirmed on 1/19/21). By Friday morning, I was feeling much better. I know have a strange metallic taste in my mouth.)
Tender feet (bottom of feet) onset 3 days after injection. Muscle weakness in arms and legs (dibiliting) 03/13/07-records received from PCP for DOS 11/27/06-02/01/07-Assessment:paresthesias of left hand. probable carpal tunnel syndrome. Myalgias. Hypertension. Hyperlipidemia. Rosacea. Osteoarthritis. C/O sense of weakness and pain in limbs. Seen by chiropractor in October or November.  PE:WNL.
A 9 year old male patient experienced fever while receiving RabAvert therapy. The child received RabAvert 1 ml intramuscularly on 07/27/04 for post exposure prophylaxis. Past medical history and concomitant medications were not provided. The patient had a possible exposure to the saliva of an unknown animal. He experienced a temperature of 102 degrees Farenheit after RabAvert was administered on 07/27/04. The family had contacted a physician (reporter) who planned on seeing the child in his office and obtaining labwork to determine if the child had an infection. The fever persisted at the time of this report. Follow up information received on 08/03/04: The patient is a 7 year old male child who experienced a viral illness while receiving RabAvert therapy. He received 3 doses of RabAvert on 07/27/04, 07/28/04 and 08/02/04 as well as Human Rabies Immune Globulin (HRIG) on 07/27/04 for exposure to a bat. The patient is described as a well child with no significant post medical history and taking no concomitant medications. The patient developed a fever and loose cough after receiving RabAvert and HRIG therapies. His lung fields were clear to auscultation and physical examination was negative. A complete Blood count including white blood cell count on 08/02/04 was normal, performed to rule out whooping cough that was a concern due to a recent outbreak in the county where the child resides. The mother was instructed to administer antipyretics for fever greater than 101 degrees Farenheit. A diagnosis of a viral illness was made. The physician reporter states that the unremitting fever is due to an intercurrent viral illness that is not related to RabAvert therapy.
Respiratory tightness; Swelling and hives behind right ear.  Child taken to emergency room.  Doctor adminstered Benadryl. 12/3/09 Hospital recs received for date 11/19/09. DX: acute allergic reaction. Pt. c/o SOB, swelling behind left ear approx 40 min after receiving H1N1 vax. Assessment: swelling with mild erythema of left ear posterior to pinna.
First injection, no issues. Second injection, 101 temp for 24 hours, intense headache 8/21/2021 I suffered an incomplete cardiac event.  I have never had any cardio issues prior to this.  I have constant pressure/pain over my left breast.
Running a fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 10Nov2023 as dose 1, single (Lot number: Unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset 11Nov2023, outcome "unknown", described as "Running a fever". Additional information: It was stated that the patient had the Pfizer COVID-19 Vaccine yesterday (10Nov2023) and was running a fever today (11Nov2023). The patient wanted to know if that is a common side effect.
Initial report received from the patient's parent on 31 July 2007. A 23-year-old female with no known allergies and no reported medical history had received a right deltoid injection of IMOVAX Rabies vaccine for pre-exposure prophylaxis on 26 July 2007, lot number unknown, and within 24 hours developed muscle aches at the site of injection and on 29 July 2007, three days post vaccination, developed abdominal pain and bloody diarrhea. It was reported that the patient had not been ill at the time of vaccination. The patient had been evaluated on 30 July 2007 by a physician. CT scan results were positive for ulcerative colitis and stool culture results are pending. A diagnosis of ulcerative colitis had not been confirmed. The patient had been scheduled for a follow-up evaluation on 31 July 2007. The patient had not recovered at the time of this report. Follow-up information received from a health care provider on 10 September 2007. Information confirming vaccine lot numbers and their sites of administration were provided by the patient's physician. The patient received a left deltoid injection of IMOVAX Rabies Vaccine, lot number Z0877-2 on 25 July 2007 and a second dose of IMOVAX Rabies Vaccine (same lot number and same site) on 27 August 2007. No adverse event had been reported after receipt of the second dose: rechallenge: negative. Lab culture specimens were obtained on 30/Jul/2007. Stool culture results: all Negative for C. Difficile Toxin A/B, salmonella, shigella, campylobacter, and E. coli. Ova/parasite Smear-Exam - Negative for helminth eggs/larvae, protozoa (Giardia and Amoebae), and Coccidia (Ctyptosporidium, Cyclospora), findings: moderate granulocytes observed. Additional information confirming the diagnosis of ulcerative colitis was not provided. The reporter stated that the, "Patient was cleared by the doctor and given a second vaccine, third vaccine due 9/10 or 9/17". No additional information was provided at this time. Follow-up information received from a health care provider on 23 October 2007. The patient continued the rabies pre-exposure series and received a third right deltoid intramuscular injection of IMOVAX Rabies Vaccine, lot number Z0877-2 on 10 September 2007. The reporter did not indicate the occurrence of any adverse events after receipt of the third dose. The reporter confirmed the patient had not received any other vaccines during the four weeks prior to receipt of the first dose of IMOVAX Rabies Vaccine. The patient was recovered at the time of the report. Follow-up information received from a health care provider on 02 January 2008. It was confirmed by the reporter that the patient had not experienced any adverse events after receiving their second and third dose of the pre-exposure IMOVAX Rabies Vaccine series. No additional information was provided at the time. Documents held by sender: Lab reports, Dr. notes.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient reported feeling numbness spread over the left side of her face and the back of the head. After waiting 45 minutes, patient reported feeling tingling in the left side of the face.
severe joint/bone pain, blurry vision, tinitis, headache, fever, dehydration, bloody nose, tired, swollen lymph nodes. Symptoms started about 6 hours after receiving booster and lasted 48 hours. Headache continued for another eight hours beyond. Injection site turned red and swollen 48 hours after receiving shot. Swollen lymph nodes persisting  72 hours after shot.
Information has been received from a consumer concerning her approximated 12 month old daughter who in 2003 was vaccinated with a dose of MMR II (lot # 645624/0274N). In 2003, the patient's mother saw a holistic healer and they said to have her daughter checked for the presence of aluminum in her body. The patient's mother reported that she believed the vaccine was responsible for aluminum in her body. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included DEXLANSOPRAZOLE (DEXILANT) for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (cold symptoms), NASAL CONGESTION (Congestion), CHEST PAIN (soreness in chest), PULMONARY PAIN (soreness in lungs) and COUGH (coughing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 050C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) After the second dose, tested positive for Covid..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided. Treatment medications were not reported.
Gave pt. MENACTRA First (R) deltoid. Then gave 1st HPV (L) Deltoid. Was talking to pt. about upcoming birthday while putting sharps in sharps container. Pt was sitting on table went to stand up and fell to the floor. Did not hit his head or hurt himself dad and I asked if he was okay, immediately grabbed a nurse.
Pt initially had a red mark at the injection site, which we advised pt was normal. But now pt claims he has had pain in his elbow since the injection. Feels the injection was given incorrectly. Dr ordered an x-ray which shows arthritis.
Rash, swelling, nausea, headache, diarrhea, muscle pain, fever, chills
The patient stated that they experience extreme flu-like symptoms, including chills, malaise and muscle aches. It lasted only one day, but the patient says that it kept them in bed for the day.
Trouble Breathing, Cough, Chest Congestion. 24 hours later: 09/29/2015 9:00 pm: Fever (101.1), Headache, Body Aches, Feeling all over sick - I guess Malaise.
Information has been received from a registered nurse concerning multiple unspecified amounts of children of unknown age and gender. On an unknown dates, the children received doses of improperly stored VARIVAX (Merck) (lot # L028276 with expire date 28-JUL-2017) (dose and route unspecified). The vaccines were stored in refrigerator temperature of 36 to 46F for 48 hours. Then they were stored at 48.7F for 18 minutes. There was no previous temperature excursion. No adverse effect was reported at this time. This was one of several reports received from same reporter. Additional information is not expected because the reporter refused additional contact.
The patient was administered improperly stored  VARIVAX; This spontaneous report has been received from a registered nurse  concerning a 12 months old male patient. The patient's concomitant therapies included sterile diluent( MERCK STERILE DILUENT). The patient's concurrent conditions, historical drugs and medical history were not reported.    On 27-AUG-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) formulation not reported but defaulted to subcutaneous injection, Lot # T002848 has been verified to be a valid lot number, expiration date 23-JAN-2022 for prophylaxis (dosage regimen was not provided).  It was reported that multiple excursions took place. One temperature excursion, was reported to had been in between -14°C to -10°C, more specifically at -12.1°C for 3 hours. A different temperature excursion, was reported to had been in between -9°C to 8°C, more specifically at -7.5°C for 8 hours and 30 minutes.  The sterile diluent used to reconstitute the Varicella virus vaccine live (oka/merck)(VARIVAX) was stored properly.  There was digital data logger involved and  no previous temperature excursion was reported.
had her vaccine three weeks ago and is now on quarantine after testing positive for Covid.; had her vaccine three weeks ago and is now on quarantine after testing positive for Covid.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had her vaccine three weeks ago and is now on quarantine after testing positive for covid on an unspecified date. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
This initial spontaneous report was received from a nurse referring to multiple unspecified patients of unknown ages and genders. There was no pertinent medical history, concomitant medications or drug allergies/drug reactions described. On unspecified dates, the patients were administered improperly stored doses of GARDASIL 9 injection (dose, route, anatomical location, lot# and expiration date were not reported). The nurse was not sure what specific vaccines were given, date of administration or to what patients. No adverse effects were reported and a product quality complaint (PQC) was not involved. It was unknown if the patients sought medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
Experienced right arm warmth, tenderness and inability and pain with raising arm above 90 degrees, started on 10/17/17.
Left arm was sore immediately following injection.  At about 2 a.m. the next morning, patient experienced a temp of 102 degrees, uncontrollable shaking, and cramps on the anterior aspect of both thighs, pulse >100.  Lasted about 2 hours.  Stayed in bed that day.
Diarrhea all day (more than 20 times); Body aches; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea all day (more than 20 times)), MYALGIA (Body aches), PYREXIA (Fever) and VOMITING (Vomiting) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011S211A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Oct-2021, the patient experienced DIARRHOEA (Diarrhea all day (more than 20 times)), MYALGIA (Body aches), PYREXIA (Fever) and VOMITING (Vomiting). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea all day (more than 20 times)), MYALGIA (Body aches), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Fever Low grade temp, rash all over bumpy with bright red splotches.  Lasted 1 week.
Hypersensitivity reaction dermatitis, urticaria, pruritus. Angioedema/anaphylactic reaction from covid infection.
Onset on June 20th (Day 1)  I took a PCR and it was positive.  I saw a doctor and got Paxlovid.  Ended on day 7.  Tested negative on 7,8 and 9.  After day 10, I had a rebound and symptoms returned on day 13.  Symptoms included congestion, cough and fatigue.  With both infections, symptoms were the same.  On day two with dose infections the symptoms were worse on day two and day three began to get better.  I tested negative again on day 16  (July 5).
Pt recvd 3 doses of Engerix-B 2AGU92 Hep B surface antibody was neg; 1OCT91 recvd 4th dose of Engerix-B; 6NOV91 HBSAB was low; pos ? immunity; 22NOV91 recvd 5th dose of Engerix-B; 17JAN92 HBSAB was pos;
This spontaneous report was received from a healthcare professional regarding a 6 month old female patient. The patient's concurrent condition was reported as seasonal allergy. On 06-OCT-2017, the patient was vaccinated with an inappropriately stored ROTATEQ lot # M044399 (expiry date: 25-JUN-2018), dose 3 via oral route for prophylaxis (dosage unspecified). Concomitant therapies included PEDIARIX, PEDVAXHIB and PREVNAR 13. No adverse event reported. Temperature excursion occurred and a Digital Data logger was involved. Sender's Comments: US-009507513-1711USA001950.
Patient experienced a burning sensation on her arm same day she received her vaccine until the next day (1/19/22). One week after her vaccination (1/26/22), patient begun having chest pain and she called her MD's office the next day still experiencing the symptoms. The patient underwent an EKG and labs at a hospital. Her EKG came out normal; however, her troponin levels were very elevated and continued to increase for 3 days while at the hospital. The hospital had her admitted for observation until she could be transferred to a different location where she could be observed by a cardiologist. Patient was transferred to facility where a cardiologist took her for care. Patient had an MRI done and undergone a stress test. Both tests resulted normal for the patient. After the patient was discharged from the hospital, her primary care physician continued for her care. She was diagnosed with a NON-STEMI due as an adverse reaction from her Moderna booster shot. Patient is at home in this moment recovering and due to start physical therapy soon as recommended from her PCP to advance her recovery. Patient had received her first two Moderna shots before without any complications.